These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 24601047)

  • 21. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
    Wang XF; Wu YH; Wang MS; Wang YS
    Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
    Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K
    Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sonographic discrimination between benign and malignant adnexal masses in premenopause.
    Radosa MP; Vorwergk J; Fitzgerald J; Kaehler C; Schneider U; Camara O; Runnebaum IB; Schleußner E
    Ultraschall Med; 2014 Aug; 35(4):339-44. PubMed ID: 23775448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic values of normal preoperative serum cancer markers for gastric cancer.
    Feng F; Sun L; Liu Z; Liu S; Zheng G; Xu G; Guo M; Lian X; Fan D; Zhang H
    Oncotarget; 2016 Sep; 7(36):58459-58469. PubMed ID: 27533455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the coronavirus pandemic on tumor markers.
    Purut YE; Giray B; Gurbuz E
    J Med Virol; 2021 Sep; 93(9):5405-5408. PubMed ID: 33932304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.
    Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A
    Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer.
    Chen ZQ; Huang LS; Zhu B
    Dis Markers; 2018; 2018():9845123. PubMed ID: 30647803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
    Chan KK; Chen CA; Nam JH; Ochiai K; Wilailak S; Choon AT; Sabaratnam S; Hebbar S; Sickan J; Schodin BA; Sumpaico WW
    Gynecol Oncol; 2013 Feb; 128(2):239-44. PubMed ID: 23063998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass.
    Goff BA; Agnew K; Neradilek MB; Gray HJ; Liao JB; Urban RR
    Gynecol Oncol; 2017 Nov; 147(2):291-295. PubMed ID: 28860006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation?
    Szekanecz E; Sándor Z; Antal-Szalmás P; Soós L; Lakos G; Besenyei T; Szentpétery A; Simkovics E; Szántó J; Kiss E; Koch AE; Szekanecz Z
    Ann N Y Acad Sci; 2007 Jun; 1108():359-71. PubMed ID: 17893999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
    Chen C; Li JD; Huang H; Feng YL; Wang LH; Chen L
    Ai Zheng; 2008 Jan; 27(1):92-5. PubMed ID: 18184473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma.
    Qiu Y; He J; Chen X; Huang P; Hu K; Yan H
    Clin Chim Acta; 2018 May; 480():186-192. PubMed ID: 29438681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative prediction of poor prognostic parameters and adjuvant treatment in women with pure endometrioid type endometrial cancer: what is the significance of tumor markers?
    Baser E; Gungor T; Togrul C; Turkoglu O; Celen S
    Eur J Gynaecol Oncol; 2014; 35(5):513-8. PubMed ID: 25423695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [1959-1999: from serum markers to 18-FDG in oncology. The experience of the René-Huguenin Center].
    Pecking AP; Mechelany-Corone C; Pichon MF
    Pathol Biol (Paris); 2000 Nov; 48(9):819-24. PubMed ID: 11141917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of CA15-3, AFP, CA19-9 and CEA tumor markers in cancer care and treatment of patients with impaired renal function on hemodialysis.
    Estakhri R; Ghahramanzade A; Vahedi A; Nourazarian A
    Asian Pac J Cancer Prev; 2013; 14(3):1597-9. PubMed ID: 23679242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of the risk of malignancy index scoring systems (1-4) used in differential diagnosis of adnexal masses.
    Ozbay PO; Ekinci T; Caltekin MD; Yilmaz HT; Temur M; Yilmaz O; Uysal S; Demirel E; Kelekci S
    Asian Pac J Cancer Prev; 2015; 16(1):345-9. PubMed ID: 25640377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining the tumor abnormal protein test with tests for carcinoembryonic antigens, cancer antigen 15-3, and/or cancer antigen 125 significantly increased their diagnostic sensitivity for breast cancer.
    Chen R; Jiang C; Zhu Q; You S; Li Y; Li S; Ding L; Meng H; Yang Y; Zha X; Wang J
    Medicine (Baltimore); 2020 Jul; 99(29):e21231. PubMed ID: 32702897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.